United Kingdom Blood Glucose Monitoring Market Insight
The United Kingdom Blood Glucose Monitoring Market is growing at an 9.1% CAGR, driven by rising diabetes prevalence, growing self-monitoring awareness, and NHS support drive the market, alongside increasing adoption of CGM systems, smart glucometers, and digital health innovations enhancing accuracy, convenience, and outcomes
United Kingdom Blood Glucose Monitoring Market Insights Forecasts to 2035
- The United Kingdom Blood Glucose Monitoring Market Size Was Estimated at USD 612.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 9.1% from 2025 to 2035
- The United Kingdom Blood Glucose Monitoring Market Size is Expected to Reach USD 1463.6 Million by 2035
Notable Insights for United Kingdom Blood Glucose Monitoring Market
- By product type, self-monitoring blood glucose (SMBG) devices dominated, accounting for approximately 55–60% share in 2024, due to their affordability and widespread usage.
- By technology, continuous glucose monitoring (CGM) is the fastest-growing segment, holding around 35–40% share, driven by real-time monitoring and improved diabetes management.
- Approximately 4.3 million people in the UK live with diabetes, with Type 2 diabetes accounting for nearly 90% of cases.
- Around 65–75% of diabetic patients actively monitor their blood glucose levels, with increasing adoption of CGM systems among younger and insulin-dependent populations.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Blood Glucose Monitoring Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Blood Glucose Monitoring Market
- Abbott Laboratories
- Roche Diagnostics
Dexcom
- Medtronic
- Ascensia Diabetes Care
- LifeScan
- Bayer AG
- Sanofi
- GlaxoSmithKline
- AstraZeneca
- Others
Recent Developments:
- In May 2025: Yuwell launched Anytime CGM in the UK, featuring a rechargeable transmitter reducing annual costs by over 35%, improving accessibility for diabetes patients.
- In February 2025: Spirit Health introduced CareSens Air, a 15-day wearable CGM delivering real-time smartphone readings, added to the NHS Drug Tariff.
- In July 2024: Roche launched Accu-Chek SmartGuide CGM in Europe, using AI to predict glucose trends and night-time hypoglycemia up to two hours in advance.
Market Segmentation:
United Kingdom Blood Glucose Monitoring Market, By Product Type
- Self-Monitoring Blood Glucose (SMBG) Devices
- Continuous Glucose Monitoring (CGM) Systems
- Testing Strips & Lancets
- Others
United Kingdom Blood Glucose Monitoring Market, By Technology
- Self-Monitoring Blood Glucose (SMBG)
- Continuous Glucose Monitoring (CGM)
- Flash Glucose Monitoring (FGM)
- Non-invasive Glucose Monitoring (Emerging Technologies)
United Kingdom Blood Glucose Monitoring Market, By End User
- Hospitals & Clinics
- Home Care Settings
- Diagnostic Centres
United Kingdom Blood Glucose Monitoring Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The UK Blood Glucose Monitoring Market is expected to grow steadily due to the increasing burden of diabetes and the shift toward digital and personalized healthcare. Experts highlight that continuous glucose monitoring systems and connected health devices will dominate future growth due to their ability to provide real-time insights and improve patient compliance. With strong NHS backing, favourable reimbursement policies, and rapid technological advancements, demand for accurate, user-friendly, and integrated glucose monitoring solutions is expected to rise, ensuring sustained market expansion through 2035.